Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1473495Generated: October 30, 2026

Trifluoroacetic acid → 8-(2-methoxy-4-(trifluoromethyl)phenyl)-N-(pyrimidin-4-yl)-1,7-naphthyridine-3-sulfonamide

https://huagongshe.com/reaction/1473495

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTrifluoroacetic acidHCID 6422—
ReactantLithium HexamethyldisilazideHCID 2733832—
ReactantN-(4-methoxybenzyl)pyrimidin-4-amineHCID 13230138—
ReactantPerfluorophenyl 8-(2-methoxy-4-(trifluoromethyl)phenyl)-1,7-naphthyridine-3-sulfonateHCID 86687549—
CatalystAcetic AcidHCID 176—
SolventDichloromethaneHCID 6344—
SolventTetrahydrofuranHCID 8028—
SolventMethanol--water (1/1)HCID 22242641—
Product8-(2-methoxy-4-(trifluoromethyl)phenyl)-N-(pyrimidin-4-yl)-1,7-naphthyridine-3-sulfonamideHCID 866875505,118.1%

Reaction Conditions

Temperature0 °C

Reaction Steps

To a vial charged with N-(4-methoxybenzyl)pyrimidin-4-amine (Intermediate OO; 28.7 mg, 0.134 mmol) was added THF (509 μl) and the resulting clear solution cooled in an ice water bath prior to the drop wise addition of lithium bis(trimethylsilyl)amide, 1.0M solution in tetrahydrofuran (26.0 μl, 0.134 mmol). The mixture was stirred for 20 min at 0° C. prior to the addition, faster than drop wise, of a solution of perfluorophenyl 8-(2-methoxy-4-(trifluoromethyl)phenyl)-1,7-naphthyridine-3-sulfonate (see EXAMPLE 322, STEP 3) (70 mg, 0.127 mmol) in THF (0.5 ml, 0.1 ml rinse). The resulting mixture was allowed to stir and warm slowly to room temp (ice melt) for 1 hr. To the mixture was added acetic acid (about 10 drops) and the resulting solution dried under reduced pressure. The crude residue was purified with a 25 g HP Silicycle column (SiliCycle, Inc. Quebec City, Canada) (0-100% EtOAc in heptane). The crude oil obtained (52 mg) was dissolved in DCM (3 ml) and TFA (0.5 ml) was added and the mixture stirred overnight at room temperature. The material was purified with a 25 g HP spherical silica column (15 μm spherical, Interchim, Mouintlucon, France) ramping DCM:MeOH (90:10) in DCM (0 to 50%) providing product, obtained as a film which was lyophilized from MeOH/H2O to afford 8-(2-methoxy-4-(trifluoromethyl)phenyl)-N-(pyrimidin-4-yl)-1,7-naphthyridine-3-sulfonamide (3 mg, 6.50 mmol, 5.11% yield) as a white powder. 1H NMR (500 MHz, DMSO-d6) δ ppm 3.69 (s, 3H) 6.77 (d, J=6.41 Hz, 1H) 7.39-7.47 (m, 2H) 7.54 (d, J=7.91 Hz, 1H) 8.08 (d, J=6.30 Hz, 1H) 8.16 (d, J=5.56 Hz, 1H) 8.44 (s, 1H) 8.75 (d, J=5.56 Hz, 1H) 8.97 (s, 1H) 9.23 (d, J=1.82 Hz, 1H). m/z (ESI) 462.2 (M+H)+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09012443B2
Source datasetuspto-grants-2015_04
ORD IDord-63d453856924443aa7261d836000ad7e
Source noteuspto-grants-2015_04